Endocrine effects of GnRH analogue with low-dose hormone replacement therapy in women with endometriosis

R Howell, Howell R, Rosemary Howell, M Dowsett, Dowsett M, Mitch Dowsett, Nicholas King, N. King, D. Keith Edmonds, Edmonds DK, D K Edmonds
Clinical endocrinology · 1995 · vol. 43(5) , pp. 609–615 · doi:10.1111/j.1365-2265.1995.tb02926.x · PMID:8548946 · W2047779724
RCT OA: closed CC0 ⤵ 4 in-corpus citations
View on OpenAlex View on PubMed View at publisher
⚙ AI-generated summary by gemini-2.5-flash-lite, 2026-06-07 ⓘ

This study found that adding hormone replacement therapy to GnRH analogue treatment suppressed FSH levels in women with endometriosis, unlike GnRH analogue alone, indicating continued pituitary responsiveness to estrogen feedback.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

OBJECTIVE: GnRH analogues are being used increasingly for a number of oestrogen dependent conditions in women. The resultant profound hypo-oestrogenism is a disadvantage, however, but the preservation of pituitary sensitivity to negative feedback by oestradiol is not well defined. We have determined the effect on gonadotrophins and inhibin of GnRH analogue plus low-dose continuous combined hormone replacement therapy in comparison with GnRH analogue therapy alone. DESIGN: Randomized controlled trial. PATIENTS: Fifty premenopausal women with endometriosis randomized to treatment with goserelin alone (Group 1) or goserelin plus 17 beta-oestradiol and medroxyprogesterone acetate (Group 2). MEASUREMENTS: FSH, LH, oestradiol, oestrone, inhibin before and during treatment. RESULTS: Oestradiol and oestrone were suppressed in both groups, but Group 2 had significantly higher oestradiol during the hormone replacement therapy period. LH was suppressed in both groups. In Group 1, FSH levels recovered during treatment but, in contrast, in Group 2, FSH levels remained suppressed throughout treatment. Inhibin was significantly lower in Group 2, but not in Group 1, during treatment compared to pretreatment. CONCLUSIONS: Pituitary secretion of FSH appears to remain responsive to feedback control by oestradiol during GnRH analogue therapy and is incompletely suppressed, unlike LH which remains completely suppressed. The possible mechanisms for this are discussed.

My notes (saved in your browser only)

Condition tags

endometriosis

MeSH descriptors

Antineoplastic Agents, Hormonal Endometriosis Estradiol Estrogen Replacement Therapy Estrogen Replacement Therapy Goserelin Medroxyprogesterone Acetate Adult Adult Antineoplastic Agents, Hormonal Antineoplastic Agents, Hormonal Endometriosis Endometriosis Endometriosis Estradiol Estradiol Estrone Estrone Estrone Feedback

Citation neighborhood (2-hop)

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. Outer rings show 2-hop neighbours — papers reached through the immediate citers/citees. [ collapse to 1-hop ]

References (27)

Cited by (4)

Source provenance

europepmc
last seen: 2026-10-16T06:09:50.462052+00:00
openalex
last seen: 2026-06-04T00:00:01.174412+00:00
pubmed
last seen: 2026-10-08T21:59:43.143194+00:00
unpaywall
last seen: 2026-10-16T06:24:35.758740+00:00
License: CC0 · commercial use OK